PERSPECTA

News from every angle

← Back to headlines

FDA Panel Supports Broader Access to Peptides, Including BPC-157

An FDA advisory committee has voted to recommend adding the popular peptide BPC-157 to the drug compounding list, a move that supports broader public access to peptides like the so-called Wolverine peptide despite scientist objections and warnings about risks.

23 Jul, 20:12 — 23 Jul, 20:12
PostShare

Sources

Showing 1 of 2 sources
FTVery High34d ago

FDA panel supports access to peptides over scientist objections

Vote is first step in broadening public access to so-called Wolverine peptide despite warnings about risks

Read full article →

Coverage Timeline

First report: Yahoo · 23 Jul, 18:32Full coverage: 2 · 2hWindow: 2h
Left-leaningCenterRight-leaning
Yahoo23 Jul, 18:32First to report

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list

2h later
FT23 Jul, 20:12Latest update

FDA panel supports access to peptides over scientist objections

Related Stories

Busy Philipps Reveals Rare Brain Tumor Diagnosis and Recovery

42m ago

FDA Approves New Pancreatic Cancer Drug Following Breakthrough Clinical Trials

1h ago

WHO Declares End of Ebola Outbreak in Uganda Amid Rising Cases in Congo

4h ago

Nutritionists Explain How Dietary Fiber Can Improve Sleep Quality

5h ago